Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Clinical cancer research

Results: 1-25/3141

Authors: Hait, WN
Citation: Wn. Hait, The prognostic and predictive values of ECD-HER-2, CLIN CANC R, 7(9), 2001, pp. 2601-2604

Authors: Baselga, J
Citation: J. Baselga, Is circulating HER-2 more than just a tumor marker?, CLIN CANC R, 7(9), 2001, pp. 2605-2607

Authors: Kurie, JM Dubois, RN
Citation: Jm. Kurie et Rn. Dubois, Prostaglandin E synthase: Another enzyme in the cyclooxygenase pathway driving epithelial cancer?, CLIN CANC R, 7(9), 2001, pp. 2608-2610

Authors: Buzaid, AC Atkins, M
Citation: Ac. Buzaid et M. Atkins, Practical guidelines for the management of biochemotherapy-related toxicity in melanoma, CLIN CANC R, 7(9), 2001, pp. 2611-2619

Authors: Buzdar, A Howell, A
Citation: A. Buzdar et A. Howell, Advances in aromatase inhibition: Clinical efficacy and tolerability in the treatment of breast cancer, CLIN CANC R, 7(9), 2001, pp. 2620-2635

Authors: Minaguchi, T Yoshikawa, H Oda, K Ishino, T Yasugi, T Onda, T Nakagawa, S Matsumoto, K Kawana, K Taketani, Y
Citation: T. Minaguchi et al., PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas, CLIN CANC R, 7(9), 2001, pp. 2636-2642

Authors: Osman, I Scher, HI Drobnjak, M Verbel, D Morris, M Agus, D Ross, JS Cordon-Cardo, C
Citation: I. Osman et al., HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer, CLIN CANC R, 7(9), 2001, pp. 2643-2647

Authors: Momoi, H Okabe, H Kamikawa, T Satoh, S Ikai, I Yamamoto, M Nakagawara, A Shimahara, Y Yamaoka, Y Fukumoto, M
Citation: H. Momoi et al., Comprehensive allelotyping of human intrahepatic cholangiocarcinoma, CLIN CANC R, 7(9), 2001, pp. 2648-2655

Authors: Ferrandina, G Ranelletti, FO Larocca, LM Maggiano, N Fruscella, E Legge, F Santeusanio, G Bombonati, A Mancuso, S Scambia, G
Citation: G. Ferrandina et al., Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer, CLIN CANC R, 7(9), 2001, pp. 2656-2661

Authors: Chung-Faye, G Palmer, D Anderson, D Clark, J Downes, M Baddeley, J Hussain, S Murray, PI Searle, P Seymour, L Harris, PA Ferry, D Kerr, DJ
Citation: G. Chung-faye et al., Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: A phase I and pharmacokinetic study of its prodrug, CB1954, CLIN CANC R, 7(9), 2001, pp. 2662-2668

Authors: Yoshimatsu, K Altorki, NK Golijanin, D Zhang, F Jakobsson, PJ Dannenberg, AJ Subbaramaiah, K
Citation: K. Yoshimatsu et al., Inducible prostaglandin E synthase is overexpressed in non-small cell lungcancer, CLIN CANC R, 7(9), 2001, pp. 2669-2674

Authors: Neben, K Moehler, T Egerer, G Kraemer, A Hillengass, J Benner, A Ho, AD Goldschmidt, H
Citation: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma, CLIN CANC R, 7(9), 2001, pp. 2675-2681

Authors: Ni, X Hazarika, P Zhang, CL Tapur, R Duvic, M
Citation: X. Ni et al., Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+cytotoxic T lymphocytes in mycosis fungoides: A potential mechanism of tumor immune escape?, CLIN CANC R, 7(9), 2001, pp. 2682-2692

Authors: Masood, R Cai, J Tulpule, A Zheng, T Hamilton, A Sharma, S Espina, BM Smith, DL Gill, PS
Citation: R. Masood et al., Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma, CLIN CANC R, 7(9), 2001, pp. 2693-2702

Authors: Hayes, DF Yamauchi, H Broadwater, G Cirrincione, CT Rodrigue, SP Berry, DA Younger, J Panasci, LL Millard, F Duggan, DB Norton, L Henderson, IC
Citation: Df. Hayes et al., Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662, CLIN CANC R, 7(9), 2001, pp. 2703-2711

Authors: Meng, MV Grossfeld, GD Williams, GH Dilworth, S Stoeber, K Mulley, TW Weinberg, V Carroll, PR Tlsty, TD
Citation: Mv. Meng et al., Minichromosome maintenance protein 2 expression in prostate: Characterization and association with outcome after therapy for cancer, CLIN CANC R, 7(9), 2001, pp. 2712-2718

Authors: Hayashibara, T Yamada, Y Miyanishi, T Mori, H Joh, T Maeda, T Mori, N Maita, T Kamihira, S Tomonaga, M
Citation: T. Hayashibara et al., Vascular endothelial growth factor and cellular chemotaxis: A possible autocrine pathway in adult T-cell leukemia cell invasion, CLIN CANC R, 7(9), 2001, pp. 2719-2726

Authors: Cairns, P Esteller, M Herman, JG Schoenberg, M Jeronimo, C Sanchez-Cespedes, M Chow, NH Grasso, M Wu, L Westra, WB Sidransky, D
Citation: P. Cairns et al., Molecular detection of prostate cancer in urine by GSTP1 hypermethylation, CLIN CANC R, 7(9), 2001, pp. 2727-2730

Authors: Ghadersohi, A Sood, AK
Citation: A. Ghadersohi et Ak. Sood, Prostate epithelium-derived ets transcription factor mRNA is overexpressedin human breast tumors and is a candidate breast tumor marker and a breasttumor antigen, CLIN CANC R, 7(9), 2001, pp. 2731-2738

Authors: Goode, EL Stanford, JL Peters, MA Janer, M Gibbs, M Kolb, S Badzioch, MD Hood, L Ostrander, EA Jarvik, GP
Citation: El. Goode et al., Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci, CLIN CANC R, 7(9), 2001, pp. 2739-2749

Authors: Migita, T Oda, Y Naito, S Morikawa, W Kuwano, M Tsuneyoshi, M
Citation: T. Migita et al., The accumulation of angiostatin-like fragments in human prostate carcinoma, CLIN CANC R, 7(9), 2001, pp. 2750-2756

Authors: Harbeck, N Alt, U Berger, U Kruger, A Thomssen, C Janicke, F Hofler, H Kates, RE Schmitt, M
Citation: N. Harbeck et al., Prognostic impact of proteolytic factors (Urokinase-Type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy, CLIN CANC R, 7(9), 2001, pp. 2757-2764

Authors: Corn, PG Heath, EI Heitmiller, R Fogt, F Forastiere, AA Herman, JG Wu, TT
Citation: Pg. Corn et al., Frequent hypermethylation of the 5 ' CpG island of E-cadherin in esophageal adenocarcinoma, CLIN CANC R, 7(9), 2001, pp. 2765-2769

Authors: Moroni, M Veronese, S Schiavo, R Carminati, O Sorensen, BS Gambacorta, M Siena, S
Citation: M. Moroni et al., Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors, CLIN CANC R, 7(9), 2001, pp. 2770-2775

Authors: Shintani, S Mihara, M Terakado, N Nakahara, Y Matsumura, T Kohno, Y Ohyama, H McBride, J Kent, R Todd, R Tsuji, T Wong, DTW
Citation: S. Shintani et al., Reduction of p12(DOC-1) expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma, CLIN CANC R, 7(9), 2001, pp. 2776-2782
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>